Ribomic (4591) Stock Overview

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan. It develops drugs in the areas of pain, heart failure, achondroplasia, osteoarthritis, diabetic retinopathy, pulmonary arterial hypertension, osteosclerosis, and fibrosis, as well as age-related macular degeneration. Ribomic Inc. has a joint research and development agreement with ASKA Pharmaceutical Co., Ltd. for drug discovery research and development targeting specific hormone receptors. The company was incorporated in 2003 and is headquartered in Tokyo, Japan.

4591 Stock Information

Symbol

4591

Address

Shirokanedai Usui BuildingTokyo, 108-0071Japan

Founded

Trading hours

Website

https://www.ribomic.com

Country

🇯🇵 Japan

Phone Number

81 3 3440 3745

Ribomic (4591) Price Chart

Ribomic Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.6648890580662159	N/A
Market Cap	$20.68M	N/A
Shares Outstanding	31.11M	10.70%
Employees	25.00	N/A
Shareholder Equity	4.38B	-6.60%

Valuation	2023	Change
P/E Ratio	-0.01	N/A
P/S Ratio	45.27	N/A
P/B Ratio	0.00	N/A

Growth	2023	Change
Return on Equity	-0.0026	N/A

Earnings	2023	Change
Revenue	$456.90K	N/A
Earnings	-$11.45M	N/A
EPS	-53.14	N/A
Earnings Yield	-79.92	N/A
Operating Margin	-27.07	N/A
Net income margin	-25.06	N/A

Financial Strength	2023	Change
Total Assets	$31.75M	N/A
Cash on Hand	$29.96M	N/A
Debt to Equity	0.0003	-18.10%
Current Ratio	$22.79	20.97%